Envoya is an AI-powered biomedical technology company developing next-generation gene delivery systems. They create polymer-based nanoparticles using FDA-approved materials for safer and more effective delivery of genetic material, enabling groundbreaking treatments for various diseases. Envoya serves academic institutions and pharmaceutical companies seeking to overcome gene therapy's delivery barriers.